Receptor-Ck and leukemogenesis
- 1 May 1998
- journal article
- review article
- Published by Elsevier in Leukemia Research
- Vol. 22 (5) , 389-394
- https://doi.org/10.1016/s0145-2126(98)00007-1
Abstract
No abstract availableThis publication has 43 references indexed in Scilit:
- Hypocholesterolemia, an unfavorable feature of prognostic value in chronic myeloid leukemiaEuropean Journal of Haematology, 2009
- Multilevel regulation of low-density lipoprotein receptor and 3-hydroxy- 3-methylglutaryl coenzyme A reductase gene expression in normal and leukemic cellsBlood, 1994
- Cholesterol inhibition, cancer, and chemotherapyThe Lancet, 1992
- HYPOCHOLESTEROLAEMIA IN MALIGNANCY DUE TO ELEVATED LOW-DENSITY-LIPOPROTEIN-RECEPTOR ACTIVITY IN TUMOUR CELLS: EVIDENCE FROM STUDIES IN PATIENTS WITH LEUKAEMIAThe Lancet, 1985
- Characterization of Low Density Lipoprotein Receptors in Freshly Isolated Leukemic Guinea Pig Lymphocytes (L2C)Journal of Receptor Research, 1985
- Elevated low density lipoprotein receptor activity in leukemic cells with monocytic differentiationBlood, 1984
- Hypocholesterolemia as a manifestation of disease activity in chronic myelocytic leukemiaCancer, 1983
- Low-density lipoprotein (LDL) receptor activity in human acute myelogenous leukemia cellsBlood, 1978
- Cholesterol as a Bioregulator in the Development and Inhibition of LeukemiaProceedings of the National Academy of Sciences, 1974
- Regulation of Cholesterol Biosynthesis in Normal and Malignant Tissues* *This research was supported by U. S. Public Health Service Grants CA-08501, CA-05200, and Research Career Award HE-01958, and by the Damon Runyon Memorial Fund Award No. 747.Current Topics in Cellular Regulation, 1970